Recently, IL-36γ-secreting CD19-CAR-T cells have been generated to promote CAR-T cell expansion and persistence (in an autocrine manner), resulting in superior anti-tumor activity in mice bearing EL4-CD19+ T lymphoblast tumor. The gene discussed is CD19; the disease is neoplasm.